Anil P. Ranganath - 25 Nov 2025 Form 4 Insider Report for TransMedics Group, Inc. (TMDX)

Reporting relationship: Senior Vice President, General Counsel and Secretary
Issuer ticker: TMDX
Reported as of: 25 Nov 2025
Net transaction value: -$154,020
SEC form: 4
Accepted by SEC: 26 Nov 2025, 16:30:07 UTC
Prior SEC filing: 10 Jun 2025
Next SEC filing: 04 Mar 2026
Source filing: View source filing
Reporting owner signature: By: /s/ Gerardo Hernandez, Attorney-in-Fact

Key filing fact

Anil P. Ranganath filed Form 4 for TransMedics Group, Inc. (TMDX) on 26 Nov 2025.

Key facts

This page summarizes Anil P. Ranganath's Form 4 filing for TransMedics Group, Inc. (TMDX).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 26 Nov 2025, 16:30.

Change

Previous filing in this sequence was filed on 10 Jun 2025.
Current net transaction value: -$154,020.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001980144 Primary reporting owner

Ranganath Anil P.

Relationship: Senior Vice President, General Counsel and Secretary
Address: C/O TRANSMEDICS GROUP, INC., 200 MINUTEMAN ROAD, ANDOVER
Signature: By: /s/ Gerardo Hernandez, Attorney-in-Fact
Signature date: 26 Nov 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TMDX transaction

Common Stock

Options Exercise

Transaction value: $281,640
Shares: +3,000
Change %: +21%
Price: $93.88
Shares after: 16,955
Date: 25 Nov 2025
Ownership: Direct

TMDX transaction

Common Stock

Sale

Transaction value: $435,660
Shares: -3,000
Change %: -18%
Price: $145.22
Shares after: 13,955
Date: 25 Nov 2025
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

TMDX transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value: $0
Shares: -3,000
Change %: -29%
Price: $0.000000
Shares after: 7,420
Date: 25 Nov 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 3,000
Exercise price: $93.88
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The price reported is a weighted average price. These shares were purchased in multiple transactions ranging from $145.00 to $145.65, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.

Footnote F2

The option vested as to 25% on June 5, 2024 and will vest as to the remaining shares in equal monthly installments over three years thereafter, subject to continued service.

SEC remarks

Senior Vice President, General Counsel and Secretary